{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:15:42Z","timestamp":1791504942871,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Jiangsu Higher Education Institutions and Nanjing Agricultural University","award":["KYJ200911"],"award-info":[{"award-number":["KYJ200911"]}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["2P41RR001081"],"award-info":[{"award-number":["2P41RR001081"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["9P41GM103311"],"award-info":[{"award-number":["9P41GM103311"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.antiviral.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T18:01:00Z","timestamp":1331402460000},"page":"179-183","source":"Crossref","is-referenced-by-count":40,"title":["Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII"],"prefix":"10.1016","volume":"94","author":[{"given":"Chen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-xia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-chao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-lin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Isahg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu-yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.03.002_b0160","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JVI.01840-06","article-title":"Antiviral peptides targeting the West Nile Virus envelope protein","volume":"81","author":"Bai","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.002_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2010.03.002","article-title":"Pichia pastoris-expressed dengue virus type2 envelope domainIII elicits virus-neutralizing antibodies","volume":"167","author":"Batra","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2012.03.002_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(00)00656-6","article-title":"Parenteral water\/oil emulsions containing hydrophilic compounds with enhanced in vivo retention: formulation, rheological characterisation and study of in vivo fate using whole body gamma-scintigraphy","volume":"215","author":"Bjerregaard","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.antiviral.2012.03.002_b0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(00)00139-3","article-title":"Delivery of peptides and proteins through the blood\u2013brain barrier","volume":"46","author":"Bickel","year":"2001","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.antiviral.2012.03.002_b0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Bharati","year":"2007","journal-title":"Med. Microbiol. Immun."},{"key":"10.1016\/j.antiviral.2012.03.002_b0030","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","article-title":"Adenosine receptor signaling modulates permeability of the blood\u2013brain barrier","volume":"31","author":"Carman","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.antiviral.2012.03.002_b0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biologicals.2010.07.004","article-title":"Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization","volume":"38","author":"Ch\u00e1vez","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.antiviral.2012.03.002_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2006.09.009","article-title":"The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry","volume":"9","author":"Chin","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2012.03.002_b0045","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbrc.2003.08.053","article-title":"Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli","volume":"309","author":"Chiu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2012.03.002_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/vir.0.80411-0","article-title":"Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein","volume":"86","author":"Chu","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.03.002_b0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2012.03.002_b0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1471-4159.2002.01201.x","article-title":"High transcytosis of melanotransferrin (P97) across the blood\u2013brain barrier","volume":"83","author":"Demeule","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.antiviral.2012.03.002_b0065","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1128\/JVI.01678-06","article-title":"Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells","volume":"80","author":"Jones","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.002_b0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","article-title":"An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells","volume":"78","author":"Hung","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.002_b0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02975283","article-title":"Prolonged systemic delivery of streptokinase using liposome","volume":"21","author":"Kim","year":"1998","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.antiviral.2012.03.002_b0170","first-page":"1073","article-title":"Synthesis and activity of new linear and cyclic peptide","volume":"44","author":"Marastoni","year":"1994","journal-title":"T derivatives Arzneimitted-Forschung."},{"key":"10.1016\/j.antiviral.2012.03.002_b0080","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1110\/ps.051844006","article-title":"NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition","volume":"15","author":"Mukherjee","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2012.03.002_b0085","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.03.002_b0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2008.05.004","article-title":"Closing the door on flaviviruses: entry as a target for antiviral drug design","volume":"80","author":"Perera","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.03.002_b0095","doi-asserted-by":"crossref","first-page":"e1000851","DOI":"10.1371\/journal.ppat.1000851","article-title":"Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate","volume":"6","author":"Schmidt","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.03.002_b0100","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1128\/JVI.01440-10","article-title":"Peptide inhibitors of flavivirus entry derived from the E protein stem","volume":"84","author":"Schmidt","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.002_b0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v3020160","article-title":"Flavivirus Cell Entry and Membrane Fusion","volume":"3","author":"Smit","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2012.03.002_b0110","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2010.02.1593","article-title":"Preparation of antigenically active recombinant yellow fever viral envelope domain III protein","volume":"14","author":"Smouse","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.002_b0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00019052-200306000-00023","article-title":"Exotic and emerging viral encephalitides","volume":"16","author":"Solomon","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.antiviral.2012.03.002_b0120","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.antiviral.2012.03.002_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2007.02.023","article-title":"Solution structure of the envelope protein domain III of dengue-4 virus","volume":"364","author":"Volk","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.03.002_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2009.09.001","article-title":"Structure of yellow fever virus envelope protein domain III","volume":"394","author":"Volk","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.03.002_b0135","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","article-title":"Structural basis of a flavivirus recognized by its neutralizing antibody","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.03.002_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2010.03.038","article-title":"Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III","volume":"403","author":"Zhang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.03.002_b0145","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.104.082974","article-title":"Delivery of \u03b2-galactosidase to mouse brain via the blood\u2013brain barrier transferrin receptor","volume":"313","author":"Zhang","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T10:31:40Z","timestamp":1543141900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0166354212000605"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.03.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}